ATH 11.1% 0.4¢ alterity therapeutics limited

Reading further into this new marker myoinsitol. In the studies...

  1. 672 Posts.
    lightbulb Created with Sketch. 49
    Reading further into this new marker myoinsitol. In the studies within the link I provided. They found a rise in this chemical, affected neurodegenerate disease such as alzhiemers and huntingtons disease, in which, AUSTEDO treats Huntingtons disease. I personally find this an awesome and interesting link, and an obvious area Dr Stamler is very privy too given his alterations and apporal of AUSTEDO.

    If he can get AUSTEDO to market, he sure can get ATH434 to market, so glad I found this gem of a stock.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $1.528K 317.5K

Buyers (Bids)

No. Vol. Price($)
102 97511267 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31179254 15
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.